FAPI PET/MRI scan for prostate cancer
Part of Cancer, Kidney & urinary clinical trials.
This trial uses a new type of PET/MRI scan (called FAPI) to see how well it can find prostate cancer. It may help doctors learn about a different way to image the cancer. You can join if you already have a scheduled or recent PSMA PET scan.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with prostate cancer
- You are scheduled for or have had a standard PSMA PET scan within the last 4 weeks
- You are willing and able to have a PET/MRI scan for this study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a special PET scan (PSMA PET) to check if prostate cancer returns after focused treatment (focal therapy). It may help find any remaining cancer that standard scans miss.
This early-phase study tests a special PET-MRI scan using rhPSMA-73 to better detect prostate cancer areas in men who would otherwise choose active surveillance. It may help doctors see where (and how much) cancer is present before deciding on treatment.
This trial tests a new type of imaging scan called FAPI PET/CT to see how well it finds the spread of prostate cancer compared to the usual PSMA PET/CT scan. If you join, you'll get an extra scan that might help doctors understand your cancer better and guide treatment decisions.
This trial uses a special PET scan to look at diseases like cancer. It aims to see if this new imaging method can help doctors find or monitor disease better. This could be helpful for people with confirmed or suspected cancer or other conditions.
This trial studies a special PET/CT scan called FAPI PET/CT to see how well it can detect or track cancerous tumors. It may help doctors better understand your cancer without extra procedures.
This trial tests a new imaging scan that combines a special PET tracer with MRI to help guide a prostate biopsy. The goal is to see if this scan can more accurately find cancer and reduce the need for extra biopsies.
Hear when a new Prostate Cancer Metastatic Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.